4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.
Source: fool.com
📰 Cap Chart News
Page 17 - Cap Chart News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cap Chart. Real-time updates on events, politics, business and more.
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.
Source: fool.com
3 Reasons to Buy Tesla, and 1 Reason to Sell
The electric vehicle maker has created massive amounts of wealth for investors, but there's one big reason to consider selling today.
Source: fool.com
3 Reasons to Buy Tesla, and 1 Reason to Sell
The electric vehicle maker has created massive amounts of wealth for investors, but there's one big reason to consider selling today.
Source: fool.com
Will Novavax Be Worth as Much as Moderna by 2025?
Novavax's vaccine candidate may soon reach commercialization.
Source: fool.com
Will Novavax Be Worth as Much as Moderna by 2025?
Novavax's vaccine candidate may soon reach commercialization.
Source: fool.com
Rivian Stock: Bull vs. Bear | The Motley Fool
This electric vehicle company is now more valuable than Lucid Group and second only to Tesla in the U.S. car market.
Source: fool.com
Airbus Flies While Boeing Flails | The Motley Fool
Only one major aircraft manufacturer is recovering from the COVID-19 pandemic right now.
Source: fool.com
2 Leading Defense Stocks to Buy in 2021 and Beyond
Like it or not, defense spending is a big part of a country's budget. And this duo should collect a fair share of that spending.
Source: fool.com
Why Is Everyone Talking About Electric Vehicle Stocks?
EV stocks are hot for good reason as the industry rapidly takes market share from gasoline-powered rivals.
Source: fool.com